CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale Director sold 15,000 shares at $30.05 ($450,765)
- 4 Open-market sale EVP, DEVELOPMENT AND CMO sold 25,000 shares at $30.09 ($752,265)
- 4 Open-market sale CEO sold 30,000 shares at $29.28 ($878,397)
- 4 Open-market sale Director sold 5,810 shares at $29.00 ($168,490)
- 4 Open-market sale CEO sold 30,000 shares at $24.15 ($724,530)
- 4 Open-market sale Director sold 10,000 shares at $28.07 ($280,669)
- 4 Open-market sale Director sold 9,190 shares at $29.15 ($267,873)
- 4 Open-market sale CEO sold 30,000 shares at $27.36 ($820,821)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 57,692 shares at $26.76 ($1,543,838)
- 4 Open-market sale Director sold 30,000 shares at an average $26.88 ($806,400)
- 4 Open-market sale CEO sold 15,000 shares at $22.89 ($343,371)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 20,000 shares at $22.22 ($444,374)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CEO sold 20,000 shares at $23.10 ($462,004)
- 4 Open-market sale Director sold 15,000 shares at $23.03 ($345,456)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 21 of 35 · 686 filings